All articles

Beyond "Normal": Baseline Health Assessment (Part 2)

Picking up from where we left off in the last entry — on disease screening — this time I'm diving into the second half of baseline testing: assessing overall health status and biological age.

Compared to the question "Do I have a disease?", this part is asking something deeper:

Is my body aging faster than it should? Which systems are already showing signs of early decline? And how far am I, really, from those age-defying icons we all admire?

Some modules also require independent tools: cellular age (methylation, telomeres), skin aging, and physical function can't be fully captured in routine tests.

Biological Age: Not Just a Number Game

Some clinics will spit out a single number for your biological age. "You're 42, but you test like 44." I don't find that number particularly useful — at least not in isolation.

Here's why:

  • Most models rely on too few or overly sensitive markers
  • The algorithms are often linear, even though aging is anything but
  • Short-term fluctuations can skew the results dramatically

So instead of fixating on one headline number, I look for something more meaningful:

Where is my aging accelerating? Which system is veering off-track? What's trending in the wrong direction — and how fast?

To make sense of this, I graded all my results using a simple traffic-light system:

  • 🟥 Red — Significant dysfunction; high risk or early disease state
  • 🟨 Yellow — Early decline; borderline status; needs attention
  • 🟩 Green — Currently robust and above-average for age

1 | The Cellular Layer: Aging Up Close

  • Epigenetic age (methylation): 44 ⚠️
  • Telomere-based age: 46 ⚠️ (For reference, my chronological age is 41.)

Both scores suggest mild acceleration. My methylation profile flagged cardiovascular-related sites as aged (~51 years🔴) — a red-zone alert — which matches findings from my blood lipids and genetic profile.

2 | The Organ Layer: A Local Status Report

Vascular System ⚠️ Hardening indices (AI, RABI/LABI), ASCVD risk, VEGF all look good. But LDL-C and homocysteine are elevated — signs of early cardiovascular risk.

Heart ✅ Key myocardial enzymes (LDH, CK, CK-MB, troponins) are all normal. No damage detected.

Liver and Gallbladder ✅ ALT, AST, GGT, ALP — all solid. Bilirubin levels are great.

Pancreas ⚠️ Serum amylase and fasting insulin are normal. But HbA1c is creeping up — borderline prediabetic. HOMA-IR is 1.5 (ideal: <1), suggesting early insulin resistance.

Kidneys ⚠️ Creatinine is on the high-normal end; eGFR slightly reduced. Uric acid remains elevated.

Bones and Muscles ⚠️ Mild spinal curvature; early lumbar bone loss; flat cervical curve. Left knee shows slight fluid and patellar softening. Muscle mass is on the low side.

Brain ⚠️ Mild frontal lobe white matter lesions (Fazekas grade 1) — a bit early at age 40.

3 | The System Layer: Is Everything Playing in Harmony?

Metabolism ⚠️ Elevated LDL-C and uric acid; HbA1c nearing prediabetic range. This system is clearly under chronic strain.

Inflammation ✅ Low levels of IL-6, IL-8, TNF-α, hsCRP — all great. But TPO-Ab is elevated, hinting at a mild autoimmune response.

Physical Function ⚠️

  • Cardio: VO2Max 41.3, excellent MET (11.8), strong anaerobic threshold
  • Strength: Right hand grip is great; left is only 85% — imbalance
  • Balance: Short single-leg stand times with eyes closed — needs work
  • Flexibility: Limited hip and thoracic mobility; poor forward/back bend

What This Tells Me

For someone in their early 40s, this pattern might be representative:

  • Few green zones, no red, lots of yellow.
  • No system is falling apart — but many are softening at the edges.
  • Several "normal" markers are inching toward risky territory.

None of this shows up under the question "Do you have a disease?"

But it's exactly what will determine whether I stay strong — or slowly slide — for the next 5–10 years.

That's why I don't see health assessment as a luxury.

I see it as a compass.

Primus · Prime Lab

Research and practice — how to live a Prime Life in full.